siRNA Library Screening Identifies a Druggable Immune-Signature Driving Esophageal Adenocarcinoma Cell Growth.
作者:
关键词
ATCC, American Type Culture CollectionBE, Barrett’s esophagusBarrett’s EsophagusEAC, esophageal adenocarcinomaERBB2, erb-b2 receptor tyrosine kinase 2ESCC, esophageal squamous cell carcinomaEsophageal AdenocarcinomaFCS, fetal calf serumGEM, gene expression microarrayGERD, gastroesophageal reflux diseaseGO, gene ontologyHGD, high-grade dysplasticIL, interleukinInflammationJAK-STAT, Janus kinase/signal transducer-and-activator of transcriptionLIF, leukemia inhibitory factorMTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromidePBS, phosphate-buffered salineRA, rheumatoid arthritisSV, somatic variationSYK, spleen tyrosine kinaseTCGA, The Cancer Genome AtlasTREM2, triggering receptor expressed on myeloid cells 2Therapeutic TargetsVEGFA, vascular endothelial growth factor AmRNA, messenger RNAsiRNA, small interfering RNA
DOI
10.1016/j.jcmgh.2018.01.012
PMID
29930979
发布时间
2022-03-21
- 浏览4

Cellular and molecular gastroenterology and hepatology
2018年5卷4期
569-590页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文